IPP Bureau

Roche to acquire Carmot Therapeutics for US$ 2.7 billion
Roche to acquire Carmot Therapeutics for US$ 2.7 billion

By IPP Bureau - December 05, 2023

Carmot Therapeutics’s R&D portfolio of clinical stage incretins has great potential to treat obesity, diabetes and potentially other diseases

PerkinElmer acquires Covaris to create an innovation-led diagnostics platform
PerkinElmer acquires Covaris to create an innovation-led diagnostics platform

By IPP Bureau - December 05, 2023

Covaris is a global leader in the development and deployment of end-to-end solutions for high-throughput genomic and proteomic analysis

Evonik launches Ecohance Soft Baobab oil for natural cosmetic formulations
Evonik launches Ecohance Soft Baobab oil for natural cosmetic formulations

By IPP Bureau - December 04, 2023

High-quality baobab oil sourced in collaboration with UNCCD and the Great Green Wall Initiative

Sulzer launches new biodegradable polymer
Sulzer launches new biodegradable polymer

By IPP Bureau - December 04, 2023

The CAPSUL solution enables optimal process performance for production of premier quality PCL grades at competitive rates

Ashland launches Perfectyl to rock skin perfection without injection
Ashland launches Perfectyl to rock skin perfection without injection

By IPP Bureau - December 04, 2023

Multi-ethnic innovation helps all complexions appear clearer and more uniform

AstraZeneca Pharma India receives permission from CDSCO to import new drug
AstraZeneca Pharma India receives permission from CDSCO to import new drug

By IPP Bureau - December 04, 2023

The receipt of this permission paves way for the launch of BREZTRI AEROSPHERE in India

India joins Executive Committee of Codex Alimentarius Commission
India joins Executive Committee of Codex Alimentarius Commission

By IPP Bureau - December 03, 2023

India had proposed for setting up the global standards for millets

Syngene concludes acquisition of biologics manufacturing facility from Stelis Biopharma
Syngene concludes acquisition of biologics manufacturing facility from Stelis Biopharma

By IPP Bureau - December 03, 2023

The acquisition will add 20,000 litres of installed biologics drug substance manufacturing capacity for Syngene

INEOS Styrolution’s NAS Eco cuts CO2 emissions by 93% in healthcare application
INEOS Styrolution’s NAS Eco cuts CO2 emissions by 93% in healthcare application

By IPP Bureau - December 03, 2023

The new ECO grade is made using renewable feedstock

Tele-MANAS Cell established at Armed Forces Medical College, Pune
Tele-MANAS Cell established at Armed Forces Medical College, Pune

By IPP Bureau - December 02, 2023

This cell will serve as an extension of the Tele Mental Health Assistance and Networking Across States initiative of the Ministry of Health and Family welfare

AIIA initiates training programme on latent tuberculosis infections
AIIA initiates training programme on latent tuberculosis infections

By IPP Bureau - December 02, 2023

The workshop is specially curated for Ayurvedic medical officers from Delhi and Haryana

Developing entrepreneurship in Ayush Sector is a priority area: Ayush Minister
Developing entrepreneurship in Ayush Sector is a priority area: Ayush Minister

By IPP Bureau - December 02, 2023

Global Ayurveda Festival organising in Thiruvananthapuram from 1st to 5th December

Venus Remedies granted market authorizations in Saudi Arabia and Philippines
Venus Remedies granted market authorizations in Saudi Arabia and Philippines

By IPP Bureau - December 02, 2023

These regulatory approvals signify a significant milestone for Venus Remedies Limited

AstraZeneca Pharma appoints Venkat Natarajan as Lead - Market Access
AstraZeneca Pharma appoints Venkat Natarajan as Lead - Market Access

By IPP Bureau - December 02, 2023

Currently, Venkat is Lead – Market Access, India at Pfizer

Lupin launches Turqoz (Norgestrel and Ethinyl Estradiol) Tablets in US
Lupin launches Turqoz (Norgestrel and Ethinyl Estradiol) Tablets in US

By IPP Bureau - December 02, 2023

Norgestrel and Ethinyl Estradiol Tablets USP (RLD: Lo/Ovral-28) had estimated annual sales of US $33 million in the US

Latest Stories

Interviews

Packaging